The Pharma Letter |
Final Data from the Phase 2 COSMOS Study of Janssen’s Once-Daily Simeprevir …
MarketWatch In Europe it is a leading cause of liver transplantation.7. The World Health Organisation (WHO) and the European Association for the Study of the Liver (EASL) estimate that 150 million people worldwide were chronically infected with HCV in 2011.8 The … New data reveals positive outcomes for hepatitis C transplant patientsEureka! Science News Sovaldi Continues to Excel in Trials with Hep C, Advanced Liver DiseaseDrug Discovery & Development |
Large Study Sheds New Light On Tissue-Type Mismatches And Their Impact On … – The MDS Beacon
Large Study Sheds New Light On Tissue-Type Mismatches And Their Impact On …The MDS BeaconA simple analogy can be helpful for better understanding the difference between low-resolution and high-resolution HLA typing. In particular, think of HLA-relate…
New advances in HCC diagnosis, staging and treatment all predicted to improve … – Medical Xpress
New advances in HCC diagnosis, staging and treatment all predicted to improve …Medical XpressIn Japanese patients, 59% were within the Milan Criteria (generally accepted set of parameters designed to assess the suitability of HCC patients for liver t…
ISHLT Releases Latest Interim Results of INSPIRE Lung Transplantation Trial … – PR Web (press release)
|
ISHLT Releases Latest Interim Results of INSPIRE Lung Transplantation Trial …
PR Web (press release) Today the latest results and research progress of the prospective INSPIRE trial, initiated in late 2011, will be announced at the International Society for Heart and Lung Transplantation’s 34th Annual Meeting and Scientific Sessions. The presentation … |
ISHLT to Announce Results of NOVEL Lung Trial Show Great Promise for … – PR Web (press release)
ISHLT to Announce Results of NOVEL Lung Trial Show Great Promise for …PR Web (press release)The International Society for Heart and Lung Transplantation (ISHLT) will announce today the one-year outcomes of the NOVEL lung trial, the first prospective …
Lifelines of Light Honors Ohioans Hoping for Organ Donation – Fox 28
Fox 28Lifelines of Light Honors Ohioans Hoping for Organ DonationFox 28Lifelines of Light Honors Ohioans Hoping for Organ Donation. Updated: Saturday, April 12 2014, 08:51 AM EDT. COLUMBUS (Sean Rowe) — On Friday night, dozens of people came together …
Lifelines of Light Honors Ohioans Hoping for Organ Donation – ABC6OnYourSide.com
Lifelines of Light Honors Ohioans Hoping for Organ DonationABC6OnYourSide.comLifelines of Light Honors Ohioans Hoping for Organ Donation. Updated: Friday, April 11 2014, 11:26 PM EDT. COLUMBUS (Sean Rowe) — On Friday night, dozens of people came toget…
ISHLT Releases Latest Interim Results of INSPIRE Lung Transplantation Trial … – DigitalJournal.com
|
ISHLT Releases Latest Interim Results of INSPIRE Lung Transplantation Trial …
DigitalJournal.com Today the latest results and research progress of the prospective INSPIRE trial, initiated in late 2011, will be announced at the International Society for Heart and Lung Transplantation’s 34th Annual Meeting and Scientific Sessions. The presentation … ISHLT to Announce Results of NOVEL Lung Trial Show Great Promise for …PR Web (press release) |
US FDA grants breakthrough theraphy designation for Celladon's Mydicar to … – pharmabiz.com
|
US FDA grants breakthrough theraphy designation for Celladon’s Mydicar to …
pharmabiz.com Celladon Corporation, a clinical-stage biotechnology company developing novel therapies for patients with heart failure and other diseases characterized by SERCA enzyme deficiencies, announced that its lead product candidate, MYDICAR, has been … |
Family Dashes For Organ Donation To Honor Organ Recipient – CBS Local
|
Family Dashes For Organ Donation To Honor Organ Recipient
CBS Local “We want people to know that there’s no end to Melika,” says Murray. Mom Roberts says Melika always led by example on the issue of organ donation. “When she turned 18, the first thing she did was check organ donor,” she says, noting she hopes others … |